TITLE

Combating HIV in the first weeks of infection may be crucial

AUTHOR(S)
Delaney, Martin
PUB. DATE
June 1992
SOURCE
Advocate;6/2/92, Issue 604, p31
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Presents news items related to AIDS in the U.S. for the week of June 2, 1992. Discussion of the anti-AIDS drugs ddI and ddC at a Food and Drug Administration committee meeting; Comparison of AZT to the drugs; Reforms to achieve faster drug-approval procedures; Planned national march against AIDS; Early treatment of HIV infections.
ACCESSION #
9673117

 

Related Articles

  • Is There A Cure For AIDS?  // Public Health Reports;May/Jun88, Vol. 103 Issue 3, p333 

    The article reveals that presently. there is no cure for AIDS. Medicines such as AZT have prolonged the lives of some patients with AIDS. There is no vaccine to prevent uninfected people from getting AIDS. The article reports that it may take years for an effective, safe vaccine to be found. It...

  • AIDS Vaccine Conference. Rockwood, Kate // Fast Company;Sep2011, Issue 158, p25 

    A timeline is presented of events following the first diagnosis of HIV 30 years ago, including the identification of the virus that causes AIDS, the first antiretroviral drug to become available for HIV treatment, called AZT, and the first phase III testing of an AIDS vaccine, AIDSVAX by VaxGen.

  • MEDICAL BRIEFS. Cohan, Gary R. // Advocate;9/7/93, Issue 637, p39 

    Presents news concerning AIDS as of September 1993. Ban on the sale of HIV tests in France; Role of AZT in HIV infection; Analysis of AIDS research in the U.S.

  • Combination Therapy for HIV Infection: Getting Closer. Fanci, Anthony S. // Annals of Internal Medicine;1/1/92, Vol. 116 Issue 1, p85 

    Editorial. Comments on issues regarding combination therapy with antiretroviral agents for HIV infection in the U.S. as of January 1992. Observations on research in combination therapy; Views on the use of zidovudine for HIV treatment; Insights on the role of surrogate markers.

  • An antiviral breakthrough. Cohan, Gary R. // Advocate;2/7/95, Issue 674, p43 

    Reports on using AZT with a new drug called 3TC as HIV treatment. Problems with the medications; Benefits and effectiveness of the drug combination.

  • Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission--Thailand, 1996-1998. Vuthipongse, P.; Bhadrakom, C.; Chaisilwattana, P.; Roongpisuthipong, A.; Chalermchokcharoenkit, A.; Chearskul, S.; Wanprapa, N.; Chokephaibulkit, K.; Tuchinda, M.; Wasi, C.; Chuachoowong, R.; Siriwasin, W.; Chinayon, P.; Asavapiriyanont, S.; Chotpitayasunondh, T.; Waranawat, N.; Sangtaweesin, V.; Horpaopan, S. // JAMA: Journal of the American Medical Association;4/8/98, Vol. 279 Issue 14, p1061 

    Examines the use of zidovudine (ZDV) to prevent perinatal infection with HIV. Testing of drug in the United States and Thailand; Effects of short-term antenatal regimen of ZDV; Methods used in research; Data collected; Estimated HIV transmission risk; Importance of study; Shorter regimen...

  • Primary Lamivudine Resistance in Acute/Early Human Immunodeficiency Virus Infection. Conway, Brian; Montessori, Valentina; Rouleau, Danielle; Montaner, Julio S.G.; O'Shaughnessy, Michael V.; Fransen, Signe; Shillington, Andrew; Weislow, Owen; Mayers, Douglas L. // Clinical Infectious Diseases;4/1/1999, Vol. 28 Issue 4, p910 

    Focuses on a study which described primary resistance to zidovudine in acute and early HIV infection. Patients and methods; Detection of drug resistance; Cases of transmission of resistant virus strains.

  • Early zidovudine treatment for patients with HIV infection.  // American Family Physician;12/1/1995, Vol. 52 Issue 8, p2358 

    Reports on a study on the use of early zidovudine treatment in asymptomatic patients with HIV infections in the United States, as presented in the August 17, 1995 issue of `New England Journal of Medicine.' Comparison between immediate and deferred zidovudine treatment; Effectiveness of...

  • Resistance to Antiretroviral Drugs: A Threat to the Prevention and Treatment of Pediatric HIV Infection. Krogstad, Paul A. // Journal of Infectious Diseases;5/15/2007, Vol. 195 Issue 10, p1393 

    The article presents a study on resistance to antiretroviral drugs, a threat to the prevention and treatment of pediatric human immunodeficiency virus (HIV) infection. Mother-to-child transmission (MTCT) of HIV were recognized as signatures of HIV infection in infants. Nucleoside analogue...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics